China · Delayed Price · Currency is CNY BMC Medical Statistics
Total Valuation
BMC Medical has a market cap or net worth of CNY 5.51 billion. The enterprise value is 3.05 billion.
| Market Cap | 5.51B |
| Enterprise Value | 3.05B |
Important Dates
The next confirmed earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
BMC Medical has 124.27 million shares outstanding. The number of shares has decreased by -0.32% in one year.
| Current Share Class | 124.27M |
| Shares Outstanding | 124.27M |
| Shares Change (YoY) | -0.32% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 29.22% |
| Owned by Institutions (%) | 19.75% |
| Float | 57.47M |
Valuation Ratios
The trailing PE ratio is 28.76 and the forward PE ratio is 19.68.
| PE Ratio | 28.76 |
| Forward PE | 19.68 |
| PS Ratio | 4.58 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | 62.50 |
| P/OCF Ratio | 44.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.91, with an EV/FCF ratio of 34.55.
| EV / Earnings | 15.86 |
| EV / Sales | 2.53 |
| EV / EBITDA | 12.91 |
| EV / EBIT | 14.18 |
| EV / FCF | 34.55 |
Financial Position
The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.81 |
| Quick Ratio | 10.01 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.56 |
| Interest Coverage | 62.67 |
Financial Efficiency
Return on equity (ROE) is 6.61% and return on invested capital (ROIC) is 32.29%.
| Return on Equity (ROE) | 6.61% |
| Return on Assets (ROA) | 3.97% |
| Return on Invested Capital (ROIC) | 32.29% |
| Return on Capital Employed (ROCE) | 6.93% |
| Weighted Average Cost of Capital (WACC) | 6.56% |
| Revenue Per Employee | 1.30M |
| Profits Per Employee | 208,180 |
| Employee Count | 923 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 5.28 |
Taxes
In the past 12 months, BMC Medical has paid 30.39 million in taxes.
| Income Tax | 30.39M |
| Effective Tax Rate | 13.29% |
Stock Price Statistics
The stock price has decreased by -27.94% in the last 52 weeks. The beta is 0.42, so BMC Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -27.94% |
| 50-Day Moving Average | 43.89 |
| 200-Day Moving Average | 53.93 |
| Relative Strength Index (RSI) | 48.52 |
| Average Volume (20 Days) | 4,620,386 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMC Medical had revenue of CNY 1.20 billion and earned 192.15 million in profits. Earnings per share was 1.54.
| Revenue | 1.20B |
| Gross Profit | 640.00M |
| Operating Income | 214.88M |
| Pretax Income | 228.61M |
| Net Income | 192.15M |
| EBITDA | 225.96M |
| EBIT | 214.88M |
| Earnings Per Share (EPS) | 1.54 |
Balance Sheet
The company has 2.53 billion in cash and 49.32 million in debt, with a net cash position of 2.48 billion or 19.95 per share.
| Cash & Cash Equivalents | 2.53B |
| Total Debt | 49.32M |
| Net Cash | 2.48B |
| Net Cash Per Share | 19.95 |
| Equity (Book Value) | 3.09B |
| Book Value Per Share | 24.59 |
| Working Capital | 2.72B |
Cash Flow
In the last 12 months, operating cash flow was 123.54 million and capital expenditures -35.35 million, giving a free cash flow of 88.19 million.
| Operating Cash Flow | 123.54M |
| Capital Expenditures | -35.35M |
| Depreciation & Amortization | 11.08M |
| Net Borrowing | -262.49M |
| Free Cash Flow | 88.19M |
| FCF Per Share | 0.71 |
Margins
Gross margin is 53.19%, with operating and profit margins of 17.86% and 15.97%.
| Gross Margin | 53.19% |
| Operating Margin | 17.86% |
| Pretax Margin | 19.00% |
| Profit Margin | 15.97% |
| EBITDA Margin | 18.78% |
| EBIT Margin | 17.86% |
| FCF Margin | 7.33% |
Dividends & Yields
This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 1.06%.
| Dividend Per Share | 0.47 |
| Dividend Yield | 1.06% |
| Dividend Growth (YoY) | 131.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.32% |
| Buyback Yield | 0.32% |
| Shareholder Yield | 1.38% |
| Earnings Yield | 3.49% |
| FCF Yield | 1.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BMC Medical is 69.29, which is 56.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 69.29 |
| Price Target Difference | 56.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 22.93% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 28, 2026. It was a forward split with a ratio of 1.4.
| Last Split Date | May 28, 2026 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
BMC Medical has an Altman Z-Score of 17.7 and a Piotroski F-Score of 6.
| Altman Z-Score | 17.7 |
| Piotroski F-Score | 6 |